Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia
- PMID: 17284133
- DOI: 10.4088/jcp.v68n0110
Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia
Abstract
Objective: Subjective well-being is considered important for compliance with antipsychotic treatment. The objective of this post hoc analysis of data from German patients in the Schizophrenia Outpatient Health Outcomes study was to investigate subjective well-being and compliance, with consideration of clinical symptoms and side effects, in outpatients diagnosed with schizophrenia.
Method: In a multicenter observational study of 2960 patients with DSM-IV-defined schizophrenia recruited between January and December 2001, subjective well-being was measured during 12 months with the Subjective Well-Being Under Neuroleptic Treatment Scale, short version (SWN-K). Compliance was self- and physician-rated. The association of compliance with clinical parameters was assessed by logistic regression.
Results: Factor analysis resulted in 3 factors: SWN-K (r2 = 0.867), clinical symptoms (r2 = 0.744), and side effects (r2 = 0.420). The odds for being compliant were 1.363 times higher if the SWN-K score increased by 20 points. Changes in positive symptoms (OR = 0.773) and changes in extrapyramidal symptoms (OR = 0.830) were found to be associated with compliance.
Conclusion: Compliance with antipsychotic medication was strongly associated with subjective well-being; further factors were clinical symptoms and side effects.
Similar articles
-
A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.Int Clin Psychopharmacol. 1995 Sep;10 Suppl 3:133-8. Int Clin Psychopharmacol. 1995. PMID: 8866775
-
Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.BMC Psychiatry. 2018 Jun 28;18(1):212. doi: 10.1186/s12888-018-1791-y. BMC Psychiatry. 2018. PMID: 29954366 Free PMC article.
-
Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.Pharmacopsychiatry. 2006 May;39(3):81-4. doi: 10.1055/s-2006-941480. Pharmacopsychiatry. 2006. PMID: 16721695
-
Subjective well-being under the neuroleptic treatment and its relevance for compliance.Acta Psychiatr Scand Suppl. 2005;(427):29-34. doi: 10.1111/j.1600-0447.2005.00542.x. Acta Psychiatr Scand Suppl. 2005. PMID: 15943008 Review.
-
Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.Aust N Z J Psychiatry. 2011 Mar;45(3):182-92. doi: 10.3109/00048674.2010.545984. Aust N Z J Psychiatry. 2011. PMID: 21438745 Review.
Cited by
-
The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial.BMC Psychiatry. 2011 Dec 28;11:203. doi: 10.1186/1471-244X-11-203. BMC Psychiatry. 2011. PMID: 22204569 Free PMC article. Clinical Trial.
-
The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life.Eur Arch Psychiatry Clin Neurosci. 2008 Apr;258(3):152-9. doi: 10.1007/s00406-007-0768-5. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 18000637
-
Medication Adherence Using Electronic Monitoring in Severe Psychiatric Illness: 4 and 24 Weeks after Discharge.Clin Psychopharmacol Neurosci. 2019 May 31;17(2):288-296. doi: 10.9758/cpn.2019.17.2.288. Clin Psychopharmacol Neurosci. 2019. PMID: 30905129 Free PMC article.
-
Preliminary data concerning the reliability and psychometric properties of the Greek translation of the 20-item Subjective Well-Being Under Neuroleptic Treatment Scale (SWN-20).Ann Gen Psychiatry. 2009 Jan 21;8:3. doi: 10.1186/1744-859X-8-3. Ann Gen Psychiatry. 2009. PMID: 19159480 Free PMC article.
-
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review.J Clin Psychopharmacol. 2016 Aug;36(4):355-71. doi: 10.1097/JCP.0000000000000523. J Clin Psychopharmacol. 2016. PMID: 27307187 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical